News
Despite this, one in five young adults who meet the criteria for the drugs are uninsured and one-third denied having a routine place for healthcare.
Earlier this year, the Centers for Medicare and Medicaid Services scrapped a previous proposal, from the Biden administration ...
1hOpinion
The New Republic on MSNGreg Abbott Goes Full Authoritarian in Wild Threat to DemocratsThe Texas governor is threatening Democrats who don’t show up to the Capitol to vote on his gerrymandered maps.
3hOpinion
The New Republic on MSNIt Sure Looks Like Republicans Edited This Birthday Photo of JD VanceEPI chief economist Josh Bivens posited that if the U.S. enters a recession in the coming months, the “rapid ...
Novo took the active ingredient of Ozempic, semaglutide, and rebranded it as Wegovy to be used specifically for weight loss.
1h
Zacks Investment Research on MSNNovo Nordisk Before Q2 Earnings: How Should Investors Play the Stock?Novo Nordisk NVO is scheduled to report its second-quarter 2025 results before the opening bell on Aug. 6, 2025. The Zacks ...
Trump administration eyes Medicare and Medicaid coverage for weight loss drugs like Wegovy and Ozempic in a five-year pilot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results